What’s Next? Five Things To Look Out For In August
Sven Dethlefs Replaces Outgoing Teva North America Head Brendan O’Grady
In the month ahead, Teva will see a key management change, Polpharma is set to wrap up a landmark Phase III biosimilar study and financial results for all manner of industry participants will continue to trickle out.
